Cardiovascular Research

Assessment of the efficacy of interventions to limit ischemic injury by direct measurement of intramural carbon dioxide tension

Authors: L D Hillis|||S F Khuri|||E Braunwald|||R A Kloner|||D Tow|||E Barsamian|||P R Maroko

Affiliations: + Expand

Abstract

Although numerous interventions have been shown to exert a salutary effect on the ischemic myocardium, the severity of ischemia generally has been measured by indirect techniques. In the present investigation the effect of ischemia on intramural carbon dioxide tension (PmCO(2)) was measured directly in the open-chest, anesthetized dog with a mass spectrometer during repetitive 10-min coronary artery occlusions separated by 45-min periods of reflow; simultaneously, regional myocardial blood flow in the ischemic area was measured by (127)Xenon washout. In all dogs the increase in PmCO(2) from before to 10 min after the first occlusion (DeltaPmCO(2)) exceeded that during subsequent occlusions. In those dogs not receiving an intervention (controls), DeltaPmCO(2) during the third occlusion was similar to that during the second occlusion. When propranolol, hyaluronidase, and nitroglycerin were administered to different groups of dogs before the third occlusion, each caused significantly smaller elevations in DeltaPmCO(2) than those occurring during the control second occlusion, and the combination of all three interventions induced the smallest increase in DeltaPmCO(2). Regional myocardial blood flow rose with hyaluronidase and was unchanged with propranolol, nitroglycerin, and the three drugs in combination. In contrast to these beneficial interventions, isoproterenol infused with the third occlusion caused a higher DeltaPmCO(2) than during the control second occlusion. It is concluded, first, that interventions that modify the severity of ischemia can be evaluated by measuring intramural carbon dioxide tension; second, that propranolol, hyaluronidase, and nitroglycerin reduce ischemic injury, whereas isoproterenol increases it; and third, that the combination of propranolol, hyaluronidase, and nitroglycerin exerts an additive beneficial effect on ischemia.

---

Chemical List

Carbon Dioxide|||Propranolol|||Hyaluronoglucosaminidase|||Nitroglycerin|||Isoproterenol

---

Reference List

Ann Intern Med. 1975 Apr;82(4):516-20|||Circulation. 1975 Jul;52(1):16-27|||J Clin Invest. 1975 Oct;56(4):978-85|||Circ Res. 1975 Oct;37(4):455-63|||Recent Adv Stud Cardiac Struct Metab. 1975;10:539-50|||Cardiovasc Res. 1976 Jan;10(1):81-90|||Am J Cardiol. 1976 Mar 31;37(4):520-7|||Am J Cardiol. 1976 Mar 31;37(4):550-6|||J Thorac Cardiovasc Surg. 1976 May;71(5):726-35|||Am J Physiol. 1964 Sep;207:661-8|||N Engl J Med. 1977 May 5;296(18):1034-41|||Cardiovasc Res. 1973 Mar;7(2):167-73|||Am J Physiol. 1973 May;224(5):1044-53|||J Thorac Cardiovasc Surg. 1974 Jul;68(1):80-9|||Cardiovasc Res. 1975 Mar;9(2):178-86|||Semin Nucl Med. 1973 Apr;3(2):153-63|||Circulation. 1974 Jun;49(6):1078-87|||Circulation. 1973 Jan;47(1):51-7|||Circ Res. 1973 Sep;33(3):353-63|||Arch Pathol. 1974 Jun;97(6):380-4|||Am J Cardiol. 1974 Jun;33(7):819-25|||J Clin Invest. 1971 Aug;50(8):1578-84|||J Appl Physiol. 1972 Feb;32(2):276-82|||Am J Cardiol. 1972 Feb;29(2):223-30|||Circulation. 1972 Sep;46(3):430-7|||Cardiovasc Res. 1970 Apr;4(2):176-9|||Circulation. 1971 Jan;43(1):67-82|||J Appl Physiol. 1968 Mar;24(3):446-50|||J Clin Invest. 1967 Sep;46(9):1402-12|||Prog Cardiovasc Dis. 1976 Sep-Oct;19(2):117-66|||Circulation. 1975 Jan;51(1):132-9|||Circulation. 1975 Apr;51(4):632-40|||N Engl J Med. 1975 Nov 13;293(20):1003-7|||N Engl J Med. 1975 Nov 13;293(20):1008-12|||N Engl J Med. 1977 Apr 21;296(16):898-903|||Circ Res. 1977 Jul;41(1):26-31|||Circ Res. 1977 Jun;40(6):566-71|||Circulation. 1977 Jun;55(6):872-80|||J Clin Invest. 1977 Aug;60(2):353-60|||Am J Cardiol. 1977 Jul;40(1):43-9|||Circulation. 1977 Nov;56(5):794-8|||Science. 1976 Oct 8;194(4261):199-200|||Circulation. 1976 Oct;54(4):591-8|||Am J Cardiol. 1976 Nov 23;38(6):689-95